Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 401243
[patent_doc_number] => 07291608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-06
[patent_title] => 'Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α'
[patent_app_type] => utility
[patent_app_number] => 10/478893
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11417
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/291/07291608.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478893 | Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α | Apr 29, 2002 | Issued |
Array
(
[id] => 1175904
[patent_doc_number] => 06747019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-08
[patent_title] => 'Low dose estrogen interrupted hormone replacement therapy'
[patent_app_type] => B2
[patent_app_number] => 10/134455
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5960
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/747/06747019.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134455
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134455 | Low dose estrogen interrupted hormone replacement therapy | Apr 29, 2002 | Issued |
Array
(
[id] => 6835155
[patent_doc_number] => 20030162701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => '19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them'
[patent_app_type] => new
[patent_app_number] => 10/257884
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9714
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257884 | 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them | Apr 16, 2002 | Issued |
Array
(
[id] => 7473980
[patent_doc_number] => 20040121993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Use of bile acid or bile salt fatty acid conjugates'
[patent_app_type] => new
[patent_app_number] => 10/474032
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2754
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474032 | Bile acid or bile salt fatty acid conjugates | Apr 14, 2002 | Issued |
Array
(
[id] => 1231687
[patent_doc_number] => 06693090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-17
[patent_title] => '19-norsteroids substituted in position 11, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them'
[patent_app_type] => B2
[patent_app_number] => 10/119903
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9813
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/693/06693090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119903 | 19-norsteroids substituted in position 11, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them | Apr 9, 2002 | Issued |
Array
(
[id] => 6721583
[patent_doc_number] => 20030055273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Novel compounds, manufacturing process, use as pigments and cosmetic composition'
[patent_app_type] => new
[patent_app_number] => 10/118453
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3524
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10118453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/118453 | Anthraquinone compounds, manufacturing process, use as pigments and cosmetic composition | Apr 8, 2002 | Issued |
Array
(
[id] => 6706810
[patent_doc_number] => 20030153544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Fatty acid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/116358
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18500
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153544.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116358 | Fatty acid derivatives | Apr 4, 2002 | Issued |
Array
(
[id] => 6736079
[patent_doc_number] => 20030013714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Aryl sulfonamides and sulfamide derivatives and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/114597
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23487
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114597 | Aryl sulfonamides and sulfamide derivatives and uses thereof | Apr 1, 2002 | Issued |
Array
(
[id] => 682607
[patent_doc_number] => 07081451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-25
[patent_title] => 'Method and apparatus for concentrating and stabilizing conjugated estrogens from mare urine'
[patent_app_type] => utility
[patent_app_number] => 10/112040
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15783
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/081/07081451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112040 | Method and apparatus for concentrating and stabilizing conjugated estrogens from mare urine | Mar 31, 2002 | Issued |
Array
(
[id] => 1314684
[patent_doc_number] => 06610844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-26
[patent_title] => 'Processes for preparation of 9,11-epoxy steroids and intermediates useful therein'
[patent_app_type] => B2
[patent_app_number] => 10/112355
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 81878
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112355
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112355 | Processes for preparation of 9,11-epoxy steroids and intermediates useful therein | Mar 28, 2002 | Issued |
Array
(
[id] => 6730764
[patent_doc_number] => 20030186954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Estriol to treat and prevent cardiovascular disease'
[patent_app_type] => new
[patent_app_number] => 10/108119
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5751
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108119 | Estriol to treat and prevent cardiovascular disease | Mar 25, 2002 | Abandoned |
Array
(
[id] => 993821
[patent_doc_number] => 06916921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds'
[patent_app_type] => utility
[patent_app_number] => 10/105939
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13420
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105939
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105939 | Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds | Mar 25, 2002 | Issued |
Array
(
[id] => 6792543
[patent_doc_number] => 20030087887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Novel fusidic acid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/100992
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18035
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10100992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/100992 | Novel fusidic acid derivatives | Mar 20, 2002 | Abandoned |
Array
(
[id] => 946619
[patent_doc_number] => 06964953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Methods for treating stress disorders using glucocorticoid receptor-specific antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/102448
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9770
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102448 | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists | Mar 18, 2002 | Issued |
Array
(
[id] => 7611191
[patent_doc_number] => 06841665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-11
[patent_title] => 'Method for synthesizing 5β, 6β-epoxides of steroids by a highly β-selective epoxidation of ΔΔ5-unsaturated steroids catalyzed by ketones'
[patent_app_type] => utility
[patent_app_number] => 10/091627
[patent_app_country] => US
[patent_app_date] => 2002-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 70
[patent_no_of_words] => 14167
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091627 | Method for synthesizing 5β, 6β-epoxides of steroids by a highly β-selective epoxidation of ΔΔ5-unsaturated steroids catalyzed by ketones | Mar 5, 2002 | Issued |
09/937320 | Use of vitamin c or the like stimulating skin cell synthesis | Mar 4, 2002 | Abandoned |
Array
(
[id] => 7227396
[patent_doc_number] => 20040073060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Process for producing a fraction enriched up to 100% of 3-0-acetyl-11-keto-beta boswellic acid from an extract containing a mixture of boswellic acids'
[patent_app_type] => new
[patent_app_number] => 10/432058
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1445
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432058 | Process for producing a fraction enriched up to 100% of 3-O-acetyl-11-keto-beta-boswellic acid from an extract containing a mixture of boswellic acids | Mar 4, 2002 | Issued |
Array
(
[id] => 6870687
[patent_doc_number] => 20030083377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Use of ERbeta-selective ligands for regulating fertility and compounds useful therefor'
[patent_app_type] => new
[patent_app_number] => 10/083685
[patent_app_country] => US
[patent_app_date] => 2002-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10259
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10083685
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/083685 | Use of ER-selective ligands for regulating fertility and compounds useful therefor | Feb 26, 2002 | Issued |
10/069282 | Antiandrogenic agents | Feb 24, 2002 | Pending |
Array
(
[id] => 6439453
[patent_doc_number] => 20020128243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Steroid sulphatase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/084235
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19062
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128243.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084235 | Steroid sulphatase inhibitors | Feb 24, 2002 | Issued |